Weekly Recap | Asymchem -9.35%, starts first buybackWeekly Review·Nov 21, 2026 at 05:51 AM06821-4.60%
Asymchem Laboratories Tianjin Discloses Share Repurchase in HKEX Next Day ReturnPUBT·Nov 20, 2026 at 09:01 AM06821-4.60%
Weekly Recap | Asymchem -3.42%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:42 AM06821-4.60%
G Sachs: Strong 3Q Orders for China's CRO and CDMO Firms Enhance Visibility for 2027AASTOCKS News·Nov 12, 2026 at 07:05 AM02359-3.61%03347-4.62%
Weekly Recap | Asymchem +19%, most brokers rate it buyWeekly Review·Nov 7, 2026 at 06:21 AM06821-4.60%
JPM: China's CDMO Sector Enters New Development Phase; Initiates Overweight on PHARMARON and ASYMCHEM H ShrsAASTOCKS News·Nov 6, 2026 at 07:03 AM03759-5.82%06821-4.60%
Asymchem climbs 6% on plan to buy back up to 700 million yuanMarket Movers·Nov 5, 2026 at 01:39 AM06821-4.60%
Asymchem Shareholders Approve Amendments to Articles at 2026 EGMTip Ranks·Oct 20, 2026 at 11:38 AM06821-4.60%002821-3.27%
Niche Plays Drive Hong Kong's Fringe Market as mRNA, Robotics Gain TractionGlobal Report·Oct 20, 2026 at 09:17 AM003890.00%00894-4.04%
Weekly Recap | Asymchem -11.85%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 06:18 AM06821-4.60%
Hong Kong's long tail: special dividends, bitcoin piles and a currency squeezeGlobal Report·Oct 13, 2026 at 10:51 AM06186-3.97%00836-1.37%